FibroBiologics Inc. to Present at the 2025 ThinkEquity Conference
I'm PortAI, I can summarize articles.
FibroBiologics Inc., a clinical-stage biotechnology company, will present at the 2025 ThinkEquity Conference on October 30 in New York City. CEO Pete O’Heeron is scheduled to speak at 4:30 p.m. ET and will be available for one-on-one investor meetings during the event. This announcement is for informational purposes only and should not be considered financial or legal advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments